Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

DNA Editor Named Runner-up Breakthrough of 2012

Published: Wednesday, February 27, 2013
Last Updated: Wednesday, February 27, 2013
Bookmark and Share
A discovery that allows life scientists to precisely edit genomes for everything from crop and livestock improvement to human gene and cell therapy was named runner-up for Science magazine's 2012 Breakthrough of the Year.

The work by Adam Bogdanove, Cornell professor of plant pathology and plant-microbe biology, joined eight other runners-up to Breakthrough of the Year -- the discovery of the Higgs boson -- in the magazine's Dec. 21 issue.

Bogdanove's breakthrough, which came in 2009 while he worked as a plant pathologist at Iowa State University, allows researchers to target and cut DNA in a living cell. Bogdanove identified a DNA targeting mechanism in proteins called TAL effectors that are used by plant pathogenic bacteria to alter gene expression in their hosts.

In 2010 he and collaborators at the University of Minnesota showed that these proteins could be used to carry an enzyme that cuts DNA, called a nuclease, that target specific DNA sequences in an organism's genome. The combination of TAL effector and nuclease is called a TALEN.

"The ability to cut DNA in living cells with TALENs allows researchers to modify DNA with higher efficiency than was previously possible," Bogdanove said. While another technology called zinc finger nucleases can also target specific genes, those nucleases are hard to make, and one company owns most of the patents. TALENs can be easily and cheaply constructed and are widely available.

TALENs give researchers the power not only to target and knock out specific gene sequences, but also to replace them with new DNA. The technology opens the door for medical applications such as gene therapy.

Depending on the nature of, say, a genetic defect, researchers may soon be able to extract a patient's cells, place them in a petri dish, remove the genetic mutation, replace that sequence with healthy code, and reintroduce the patient's own cells, now fixed, Bogdanove said.

Similarly, plant breeders may use TALENs to sidestep traditional breeding of crops by inserting new, site-specific genetic information, he added.

Bogdanove is working to further understand the basic biology of plant bacteria interactions with TAL effectors. "In that context, we expect to learn fundamental things of how these proteins interact with DNA that further inform technology development," he said.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Tumor-suppressing Gene Lends Insight to Cancer Treatment
Researchers have found that delicate replication process derails if a gene named PTEN has mutated or is absent.
Tuesday, July 14, 2015
Computer Model Reveals Cancer's Energy Source
Findings focused on the energy-making process in cancer cells known as the Warburg Effect.
Tuesday, August 19, 2014
For Cancer Patients, Sugar-Coated Cells are Deadly
Paszek’s lab will focus on developing high-resolution microscopy to further study cell membrane-related cancer mechanisms.
Friday, June 27, 2014
Gold-Plated Nano-Bits Find, Destroy Cancer Cells
Scientists have merged tiny gold and iron oxide particles, then added antibody guides to steer them through the bloodstream toward colorectal cancer cells.
Monday, October 21, 2013
Genetic Switches Play Big Role in Human Evolution
Study offers further proof that the divergence of humans from chimpanzees was profoundly influenced by mutations to DNA sequences.
Wednesday, June 12, 2013
Turn out the Light: 'Switch' Determines Cancer Cell Fate
Like picking a career or a movie, cells have to make decisions – and cancer results from cells making wrong decisions.
Friday, May 03, 2013
Nano Compartments May Aid Drug Delivery, Catalyst Design
Spongelike nanoparticles whose pores can be filled with drugs offer the promise of drug delivery to specific targets in the body, avoiding unpleasant side effects.
Monday, April 22, 2013
Scientists Develop World's Smallest Drug Deliverer
Cornell researchers have created a pore in “Cornell Dots” – brightly glowing nanoparticles nicknamed C-Dots – that can carry medicine.
Friday, April 12, 2013
Organic Metamaterial Flows like a Liquid, Remembers its Shape
A bit reminiscent of the Terminator T-1000, a new material created by Cornell researchers is so soft that it can flow like a liquid and then, strangely, return to its original shape.
Tuesday, December 04, 2012
Study: How Cells form 'Trash Bags' for Recycling Waste
A class of membrane-sculpting proteins create vesicles that carry old and damaged proteins from the surface of cellular compartments into internal recycling plants where the waste is degraded and components are reused.
Tuesday, October 23, 2012
Metastatic 'Switch' Sheds New Light on Colon Cancer
What kills cancer patients often isn't the primary tumor; it's when the tumor metastasizes - or spreads the cancer to other areas of the body.
Tuesday, September 11, 2012
The Force is with us: GEDI Chip Sorts Prostate Cancer Cells
Geometrically Enhanced Differential Immunocapture chip identify and collect cancer cells from a patient's bloodstream.
Friday, June 29, 2012
Some Stem Cells Can Trigger Tumors
When in contact with even trace amounts of cancer cells, stem cells can create a microenvironment suitable for more tumors to grow.
Wednesday, June 06, 2012
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
New Material Opens Possibilities for Super-Long-Acting Pills
A pH-responsive polymer gel could create swallow able devices, including capsules for ultra-long drug delivery.
New Tool For Investigating RNA Gone Awry
A new technology – called “Sticky-flares” – developed by nanomedicine experts at Northwestern University offers the first real-time method to track and observe the dynamics of RNA distribution as it is transported inside living cells.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
TOPLESS Plants Provide Clues to Human Molecular Interactions
Scientists at Van Andel Research Institute have revealed an important molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!